Evidence map›Paper›PMID 41909837›Full record

ArticleFrontiers in cellular and infection microbiology2026

O2a O-antigen type and sepsis in invasive

Mengyan Li, Minghao Gu, Hong Wang, Yi Sun, Shan Jiang, Xiangke Wang, Shengyao Wang, Mingyu Wang, Sensen Lv, Xiudi Han and 1 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mengyan LiDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Minghao GuDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Hong WangDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Yi SunDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Shan JiangDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Xiangke WangDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Shengyao WangDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Mingyu WangDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Sensen LvDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Xiudi HanDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.
Xuedong LiuDepartment of Respiratory and Critical Care Medicine, Qingdao Municipal Hospital, Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Invasive Methods: This retrospective cohort study screened all consecutive patients with culture-confirmed KP infection at Qingdao Municipal Hospital (November 2016-October 2023) and identified invasive cases based on isolation from normally sterile sites; only the first invasive episode per patient was included. Sepsis was defined according to Sepsis-3 criteria. Antimicrobial susceptibility testing was performed routinely, and resistance phenotypes (CRKP/ESBL/MDR) were derived from susceptibility results. All isolates underwent whole-genome sequencing (paired-end 150 bp) on the MGI Tech MGISEQ-2000 platform; serotypes, sequence types, and virulence determinants were inferred using Kleborate. Core-genome SNP phylogenies were reconstructed using Snippy with recombination filtered by Gubbins and maximum-likelihood inference by IQ-TREE. Multivariable logistic regression was used to identify factors associated with sepsis. Results: Among 127 patients with invasive KP infection, the incidence of sepsis was 55.1% (70/127). In prespecified multivariable logistic regression models, bloodstream infection, higher PCT levels, and lymphocyte counts <1×10^9/L were associated with higher odds of sepsis after multivariable adjustment. Regarding pathogen-related factors, a "replacement exposure" strategy was applied by entering O2a, K64, and the ST11-K64 clonal background separately; O2a (OR 6.777, 95% CI 1.118-41.070), K64 (OR 16.674, 95% CI 1.588-175.022), and ST11-K64 (OR 19.525, 95% CI 1.991-191.461) were each significantly associated with sepsis, and Firth's penalized regression yielded directionally consistent results, supporting robustness under sparse-data/separation concerns. Cross-tabulation analyses further demonstrated strong aggregation between O2a and K64 as well as the ST11-K64 background (K64 present in 83.3% and ST11-K64 in 77.8% of O2a-positive isolates, versus 0.9% and 0% among O2a-negative isolates, respectively), indicating that O2a and K64 predominantly arose from a high-risk ST11-K64 clonal subgroup. Phylogenetic analysis showed that this ST11-K64 lineage largely overlapped with carbapenem-resistant Conclusion: In this retrospective cohort of invasive KP infections, O2a was associated with a higher likelihood of sepsis. Given the strong clustering of O2a with the ST11-K64 clonal background and carbapenem-resistant phenotypes, O2a is more likely to serve as a clinically observable adjunct marker of a high-risk clonal/resistance lineage. These findings suggest the potential incremental value of O2a for early risk stratification, which warrants further evaluation for informing sepsis surveillance and assessment of resistance risk.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeO AntigensSepsisAgedAnti-Bacterial AgentsFemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedPhylogenyPolymorphism, Single NucleotideRetrospective StudiesSerogroupVirulenceAnti-Bacterial AgentsO AntigensVirulence Factorsinvasive infectionKlebsiella pneumoniaelipopolysaccharideO2asepsis

Identifiers

PMID41909837
PMCPMC13021795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.